Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.570
+0.180 (5.31%)
At close: Feb 6, 2026, 4:00 PM EST
3.576
+0.006 (0.17%)
After-hours: Feb 6, 2026, 7:11 PM EST
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $386.79 million as of February 6, 2026. Its market cap has increased by 112.41% in one year.
Market Cap
386.79M
Enterprise Value
221.83M
1-Year Change
112.41%
Ranking
Category
Stock Price
$3.57
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from $214.50M to $386.79M, an increase of 80.32%. That is a compound annual growth rate of 5.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 386.80M | 18.61% |
| Dec 31, 2025 | 326.10M | 84.13% |
| Dec 31, 2024 | 177.10M | 138.04% |
| Dec 29, 2023 | 74.40M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.98% |
| Dec 31, 2021 | 890.20M | 220.56% |
| Dec 31, 2020 | 277.70M | 255.12% |
| Dec 31, 2019 | 78.20M | -74.15% |
| Dec 31, 2018 | 302.50M | -60.22% |
| Dec 29, 2017 | 760.40M | 30.72% |
| Dec 30, 2016 | 581.70M | 7.13% |
| Dec 31, 2015 | 543.00M | 153.15% |
| Oct 7, 2015 | 214.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Absci | 398.48M |
| Monopar Therapeutics | 396.48M |
| Enanta Pharmaceuticals | 388.56M |
| Allogene Therapeutics | 387.66M |
| Bicycle Therapeutics | 384.99M |
| Greenwich LifeSciences | 383.08M |
| Anavex Life Sciences | 375.26M |
| Immutep | 374.67M |